Functional differences between low- and high-affinity CD8+ T cells in the tumor environment
Weak T-cell antigen receptor (TCR)-ligand interactions are sufficient to activate naïve CD8 + T cells, but generally do not result in tumor eradication. How differences in TCR affinity affect the regulation of T-cell function in an immunosuppressive tumor environment has not been investigated. We ha...
Saved in:
Published in | Oncoimmunology Vol. 1; no. 8; pp. 1239 - 1247 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
Taylor & Francis
01.11.2012
Landes Bioscience |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Weak T-cell antigen receptor (TCR)-ligand interactions are sufficient to activate naïve CD8
+
T cells, but generally do not result in tumor eradication. How differences in TCR affinity affect the regulation of T-cell function in an immunosuppressive tumor environment has not been investigated. We have examined the functional differences of high- vs. low-affinity CD8
+
T cells and we observed that infiltration, accumulation, survival and cytotoxicity within the tumor are severely impacted by the strength of TCR-ligand interactions. In addition, high-affinity CD8
+
T cells were found to exhibit lower expression of inhibitory molecules including PD-1, LAG-3 and NKG2A, thus being less susceptible to suppressive mechanisms. Interferon γ and autocrine interleukin-2 were both found to influence the level of expression of these molecules. Interestingly, although high-affinity CD8
+
T cells were superior to low-affinity CD8
+
T cells in their ability to effect tumor eradication, they could be further improved by the presence of tumor specific CD4
+
T cells. These findings illustrate the importance of both TCR affinity and tumor-specific CD4 help in tumor immunotherapy. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 2162-4011 2162-402X 2162-402X |
DOI: | 10.4161/onci.21285 |